Edward M. Kaye M.D., Director at Stoke Therapeutics, Inc. (STOK), sold 21,704 shares at $32.52 ($702K) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($702k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.44 | 3,825 | $120K | 17.1% |
| 2 | $32.52 | 8,274 | $269K | 38.3% |
| 3 | $32.52 | 8,274 | $269K | 38.3% |
| 4 | $33.10 | 1,331 | $44K | 6.3% |
| Total | $32.37 avg | 21,704 | $702K | 100% |
| Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |
| CYTK | SELL | 2025-12-02 | $3.7M | — | Filing → |